PTC Therapeutics reported $9.98 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Acadia Pharmaceuticals USD 13.7 2.49 Sep/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amgen USD 25.31 15.82 Dec/2025
Biogen USD 14.02 4.63 Dec/2025
BioMarin Pharmaceutical USD 19.24 0.21 Dec/2025
Daiichi Sankyo JPY 20.73 1.74 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
Gilead Sciences USD 15.63 0.08 Dec/2025
Incyte USD 14.84 2.79 Dec/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
Ironwood Pharmaceuticals USD 204.24 88.19 Dec/2024
Novartis USD 15.74 0.15 Sep/2025
Pfizer USD 14.48 5.18 Dec/2025
PTC Therapeutics USD 9.98 3.25 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Roche Holding CHF 16.09 3.51 Dec/2025
Sarepta Therapeutics USD 27.27 0 Jun/2025
TG Therapeutics USD 13.08 75.69 Sep/2025
Vertex Pharmaceuticals USD 26.15 2.22 Dec/2025
Xencor USD 29.92 3.22 Sep/2022